17- N,N- diethylcarbamoyl- 4- methyl- 4- azaandrostane- 3- one (DMAA)

Subscribe to Selected New Research on 17-N,N-diethylcarbamoyl-4-methyl-4-azaandrostane-3-one

50 relevant articles (4 outcomes, 7 trials/studies) found for this Bio-Agent

Description: inhibitor of testosterone 5-alpha reductase, receptor binding & nuclear uptake of androgens in the prostate

Also Known As:

DMAA; 17 beta-N,N-diethylcarbamoyl-4-methyl-4-aza-5 alpha-androstan-3-one; 17-N,N-diethyl-4-methyl-3-oxo-4-azaandrostane-17-carboxamide; 4-MA; 4MA compound; 4-Azaandrostane-17-carboxamide, N,N-diethyl-4-methyl-3-oxo-, (5alpha,17beta)-

Relationship Network

Bio-Agent Context: Research Results

Polycyclic Compounds: 58

Steroids: 13691

Androstanes: 6

Androstanols

Dihydrotestosterone: 1037

17-N,N-diethylcarbamoyl-4-methyl-4-azaandrostane-3-one: 50

Heterocyclic Steroids

Azasteroids

17-N,N-diethylcarbamoyl-4-methyl-4-azaandrostane-3-one: 50

Hormones, Hormone Substitutes, and Hormone Antagonists

Hormones: 44075

Gonadal Hormones: 245

Gonadal Steroid Hormones: 2145

Testosterone Congeners: 17

Dihydrotestosterone: 1037

17-N,N-diethylcarbamoyl-4-methyl-4-azaandrostane-3-one: 50

Experts

1.	Oznur, Ali: 1 article (10/2006)

Related Diseases

1.	Hallux Valgus (Bunion) 09/01/2002 - "The hallux valgus angle was improved from an average of 25 degrees to 14 degrees, the first intermetatarsal angle from 12 degrees to 8 degrees and the DMAA from 15 degrees to 5 degrees" 09/01/1998 - "The hallux valgus angle was improved from an average of 22 degrees to 18 degrees, the intermetatarsal angle from 11 degrees to 9 degrees, and the DMAA from 16 degrees to 9 degrees" 10/01/2004 - "BACKGROUND: The aim of this study was to determine if there are intraobserver and interobserver differences in reliability when measuring hallux valgus angles (HVA), 1-2 intermetatarsal angles (IMA), and distal metatarsal articular angles (DMAA) manually compared to computer-assisted means" 08/01/2002 - "This study suggests that there may be limited value in the DMAA as a clinical measure as it varies with examiner and with the hallux valgus angle." 10/01/2006 - "Technical Tip: mini-fixator assisted correction of DMAA in hallux valgus surgery." Get all the results and reference details, order at left...
2.	Congenital Abnormalities (Deformity) 01/01/2008 - "IMA and DMAA were not significant for prediction of postoperative HVA in logistic regression, although they were significantly increased in larger deformities" 11/01/1995 - "Early onset was characterized by increased deformity and an increased DMAA" 09/01/2001 - "Intermediate deformity with a normal DMAA can be corrected by displacement osteotomies, and high DMAA can be corrected by rotated scarf of double osteotomy, which includes a base osteotomy to correct the intermetatarsal angle and a distal osteotomy, such as Riverdin, to correct the DMAA" 09/01/2001 - "If a mild deformity has a high DMAA, it can be corrected by a distal rotated chevron osteotomy" 11/01/1995 - "A Chevron osteotomy or McBride procedure was used for mild deformities, a distal soft tissue procedure with proximal first metatarsal osteotomy was used for moderate and severe deformities with MTP subluxation, and a double osteotomy (extra-articular correction) was used for moderate and severe deformities with an increased distal metatarsal articular angle (DMAA)" Get all the results and reference details, order at left...
3.	Prostatic Neoplasms (Prostate Cancer) 07/01/1991 - "The present data show that the inhibitory effects of 4-MA (17 beta, N,N-diethylcarbamoyl-4-methyl-4-aza-5 alpha-androstan-3-one) and of the antiandrogen Flutamide are additive on prostatic growth and on androgen-sensitive prostatic binding protein mRNA levels in the rat, thus clearly suggesting that such a combination could provide the basis for a further improvement in the therapy of prostate cancer." Get all the results and reference details, order at left...
4.	Dementia (Dementias) 01/01/2004 - "SEARCH STRATEGY: Trials were identified from a search of the Trial-based Specialized Register of the Cochrane Dementia and Cognitive Improvement Group on 7 April 2004 using the terms: memantin, namenda, ebixa, axura, D-145, DMAA, DRG-0267" 01/01/2003 - "SEARCH STRATEGY: Trials were identified from a search of the Specialized Register of the Cochrane Dementia and Cognitive Improvement Group on 15 April 2003 using the terms: memantin, D-145, DMAA, DRG-0267" 01/01/2003 - "SEARCH STRATEGY: Trials were identified from a search of the Trial-based Specialized Register of the Cochrane Dementia and Cognitive Improvement Group on 9 October 2002 using the terms: memantin, D-145, DMAA, DRG-0267" Get all the results and reference details, order at left...
5.	DNA Damage 11/01/1999 - "In the present study, the intracellular behavior of Hsp72 was investigated during the recovery from the DNA damage induced by exposure to DMAA" 04/01/1996 - "These findings indicate that the DMAA treatment may be an effective tool to reveal DNA damage induced by 0 -(2), which to date has not been sufficiently clarified." 04/01/1996 - "The result suggests that 0 -(2) caused DNA damage, which became detectable as ssb by the treatment using DMAA" 08/01/2004 - "In conclusion, DMAA exposure causes oxidative stress, DNA damage and specific induction of apoptosis in target organs of arsenic carcinogenesis, which may be attributable to the mechanism(s) of arsenic-induced carcinogenesis in rodents" 12/01/1997 - "These results indicate that DMAA has the potential to promote rat liver carcinogenesis, possibly via a mechanism involving stimulation of cell proliferation and DNA damage caused by oxygen radicals." Get all the results and reference details, order at left...
26 Diseases and 50 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Messenger RNA (mRNA)
2.	Flutamide (Eulexin)
3.	Carrier Proteins (Binding Protein)
4.	Memantine (Namenda)
5.	polyterephthalic acid anhydride
6.	Cacodylic Acid (Cacodylate)
7.	Arsenic
8.	Cholestenone 5 alpha-Reductase (5 alpha-Reductase)
9.	monomethylarsonic acid (MSMA)
10.	Aphidicolin
43 Drugs and Important Bio-Agents and 34 more articles analyzed in the Research Interface, order at left...

Related Therapies and Procedures

1.	Osteotomy
1 Therapies and Procedures and 5 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>